Connect your AI

AnaptysBio, Inc. ANAB Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

Eli LillyLLY

3.1%+1.6pp

PfizerPFE

6.8%—

AmgenAMGN

4.1%+0.6pp

Regeneron PharmaceuticalsREGN

5.4%-1.1pp

BiogenBIIB

5.3%-2.1pp

Other financials

Income statement

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Calculated from AnaptysBio, Inc.’s reported figures.

net income/market cap=-9.9%

Based on trailing twelve months.

The official record: AnaptysBio, Inc.’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AnaptysBio, Inc.'s earnings yield?: AnaptysBio, Inc. (ANAB) reported earnings yield of -9.9% in Q3 2025.
How has AnaptysBio, Inc.'s earnings yield changed year-over-year?: AnaptysBio, Inc.'s earnings yield increased by 39.7% year-over-year, from -16.4% to -9.9%.
What is the long-term trend for AnaptysBio, Inc.'s earnings yield?: Over 3 years (2021 to 2024), AnaptysBio, Inc.'s earnings yield has grown at a 81.6% compound annual growth rate (CAGR), from -6% to -36%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.